Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.52B |
| 2 |
Apple
AAPL
|
+$645M |
| 3 |
Amazon
AMZN
|
+$557M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$392M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$354M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$262M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| 1 | Technology | 23.15% |
| 2 | Financials | 13.74% |
| 3 | Communication Services | 10.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
3076
DELISTED
Molecular Templates, Inc.
MTEM
| $107K | ﹤0.01% |
911
-630
| -41% | -$74K |
|
|
OMP
3077
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $107K | ﹤0.01% |
+4,566
| New | +$107K |
|
3078
Invesco CurrencyShares Swiss Franc Trust
FXF
$378M
| $105K | ﹤0.01% |
1,077
-18,583
| -95% | -$1.81M |
|
|
STKL
3079
SunOpta
STKL
$755M
| $105K | ﹤0.01% |
8,611
+4,300
| +100% | +$52.4K |
|
|
TWN
3080
Taiwan Fund
TWN
$339M
| $105K | ﹤0.01% |
2,980
+1,000
| +51% | +$35.2K |
|
3081
Cidara Therapeutics
CDTX
$1.64B
| $104K | ﹤0.01% |
2,571
-35
| -1% | -$1.42K |
|
3082
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $104K | ﹤0.01% |
920
-6,060
| -87% | -$685K |
|
3083
Silicom
SILC
$104M
| $103K | ﹤0.01% |
2,346
+1,246
| +113% | +$54.7K |
|
|
ATHX
3084
DELISTED
Athersys, Inc. Common Stock
ATHX
| $103K | ﹤0.01% |
2,847
-2,998
| -51% | -$108K |
|
3085
First Savings Financial Group
FSFG
$193M
| $102K | ﹤0.01% |
4,170
-3,057
| -42% | -$74.8K |
|
3086
UroGen Pharma
URGN
$891M
| $102K | ﹤0.01% |
6,700
-13,368
| -67% | -$204K |
|
3087
Universal Technical Institute
UTI
$1.54B
| $102K | ﹤0.01% |
15,745
-23,331
| -60% | -$151K |
|
3088
Northeast Bank
NBN
$946M
| $101K | ﹤0.01% |
3,379
-3,027
| -47% | -$90.5K |
|
3089
Stoneridge
SRI
$232M
| $101K | ﹤0.01% |
3,388
-18,812
| -85% | -$561K |
|
|
BCEL
3090
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $101K | ﹤0.01% |
11,983
-17,489
| -59% | -$147K |
|
3091
BlueLinx
BXC
$651M
| $100K | ﹤0.01% |
1,996
-8,610
| -81% | -$431K |
|
3092
Global X Genomics & Biotechnology ETF
GNOM
$46.6M
| $100K | ﹤0.01% |
+1,000
| New | +$100K |
|
3093
Theravance Biopharma
TBPH
$690M
| $100K | ﹤0.01% |
6,868
-44,452
| -87% | -$647K |
|
3094
Peabody Energy
BTU
$2.25B
| $99K | ﹤0.01% |
12,485
-39,985
| -76% | -$317K |
|
|
FBMS
3095
DELISTED
The First Bancshares, Inc.
FBMS
| $99K | ﹤0.01% |
2,636
-14,421
| -85% | -$542K |
|
3096
Silicon Laboratories
SLAB
$4.45B
| $98K | ﹤0.01% |
634
-87,103
| -99% | -$13.5M |
|
3097
AnaptysBio
ANAB
$649M
| $97K | ﹤0.01% |
3,725
-14,174
| -79% | -$369K |
|
3098
Horizon Bancorp
HBNC
$842M
| $97K | ﹤0.01% |
5,528
-30,225
| -85% | -$530K |
|
3099
LCNB Corp
LCNB
$230M
| $97K | ﹤0.01% |
5,956
-4,212
| -41% | -$68.6K |
|
|
MESO
3100
Mesoblast
MESO
$1.97B
| $97K | ﹤0.01% |
6,500
+6,050
| +1,344% | +$90.3K |
|